Thymosin alpha 1 data

ALBM (Bethesda, Md.) published data from a non-blinded trial in 40 HIV-infected patients. Patients received either AZT alone; AZT plus Thymosin alpha 1; AZT plus alpha interferon; or AZT, alpha interferon and Thymosin alpha 1.

Patients given the agent along with AZT and alpha interferon showed an increase in CD4+ cell counts, ALBM said. As reported in the International Journal of Clinical & Laboratory Research, the year-long, early Phase II study in Italy showed no adverse effects, except for the fever and flu-like symptoms associated with interferon. ...